In a filing, Harvard Bioscience Inc. revealed its Chief Executive Officer Green James W acquired Company’s shares for reported $29100.0 on Jun 13 ’24. In the deal valued at $2.91 per share,10,000 shares were bought. As a result of this transaction, Green James W now holds 3,111,091 shares worth roughly $8.87 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Green James W bought 20,000 shares, generating $61,400 in total proceeds. Upon buying the shares at $3.07, the Chief Executive Officer now owns 3,101,091 shares.
Before that, Green James W bought 25,000 shares. Harvard Bioscience Inc. shares valued at $109,500 were divested by the Chief Executive Officer at a price of $4.38 per share. As a result of the transaction, Green James W now holds 2,862,679 shares, worth roughly $8.16 million.
The Benchmark Company upgraded its Harvard Bioscience Inc. [HBIO] rating to a Buy from a a Speculative buy in a research note published on March 10, 2023; the price target was increased to $4 from $3. A number of analysts have revised their coverage, including The Benchmark Company’s analysts, who increased its forecast for the stock in early January from “a Speculative buy” to “a Buy”. Northland Capital began covering HBIO with “an Outperform” recommendation on December 09, 2020. KeyBanc Capital Markets started covering the stock on November 10, 2020. It rated HBIO as “an Overweight”.
Price Performance Review of HBIO
On Friday, Harvard Bioscience Inc. [NASDAQ:HBIO] saw its stock fall -1.72% to $2.85. Over the last five days, the stock has gained 1.06%. Harvard Bioscience Inc. shares have fallen nearly -46.73% since the year began. Nevertheless, the stocks have fallen -49.11% over the past one year. While a 52-week high of $5.88 was reached on 01/02/24, a 52-week low of $2.75 was recorded on 06/11/24. SMA at 50 days reached $3.30, while 200 days put it at $4.17. A total of 1.17 million shares were traded, compared to the trading of 0.23 million shares in the previous session.
Levels Of Support And Resistance For HBIO Stock
The 24-hour chart illustrates a support level at 2.80, which if violated will result in even more drops to 2.75. On the upside, there is a resistance level at 2.94. A further resistance level may holdings at 3.03. The Relative Strength Index (RSI) on the 14-day chart is 36.24, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.00, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 63.64%. Stochastics%K at 42.27% indicates the stock is a holding.
